NCT07015697 A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT07013760 Characterize and Assess Clinical Outcomes of Patients Receiving Tezepelumab After Marketing Approval in Spain Status COMPLETED Phase N/A
NCT07013643 A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity Status RECRUITING Phase PHASE1
NCT07013123 Potency of HDM Sublingual AIT Tablets in Assuring the Persistency of Asthma Control in HDM Allergic Patients With Severe Asthma, Treated With Tezepelumab Status NOT_YET_RECRUITING Phase PHASE3
NCT07008963 Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant Status COMPLETED Phase N/A
NCT07007793 A Study to Assess Efficacy and Safety of Baxdrostat in Participants With Primary Aldosteronism Status RECRUITING Phase PHASE3
NCT07005128 A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) Status RECRUITING Phase PHASE3
NCT07000357 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event Status RECRUITING Phase PHASE3
NCT07000149 A Study to Investigate the Efficacy and Safety of Volrustomig ± Casdatifan vs Nivolumab + Ipilimumab as 1L Treatment for Advanced ccRCC Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT07000136 A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With HeFH Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT07000123 A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06998095 Tezepelumab (Tezspire) Regulatory Postmarketing Surveillance in Korea Status NOT_YET_RECRUITING Phase N/A
NCT06996886 A Study in Healthy Participants to Investigate Relative Bioavailability of AZD5004 in Three Solid Oral Formulations Status COMPLETED Phase PHASE1
NCT06996782 A Platform Study in Non-Small Cell Lung Cancer (NSCLC) Status RECRUITING Phase PHASE1/PHASE2
NCT06995833 Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance Status RECRUITING Phase N/A
NCT06995820 A Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of AZD1613 in Healthy Participants. Status RECRUITING Phase PHASE1
NCT06992609 Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer. Status RECRUITING Phase PHASE3
NCT06991946 Patient-Centric Study to Assess the Impact of Genomic Profiling on the Treatment of Patients With Metastatic Breast Cancer in Spain Status RECRUITING Phase N/A
NCT06989983 A Study Designed to Assess the Mass Balance Recovery, Absorption, Metabolism, Excretion of [14C]AZD5462 and the Absolute Bioavailability of AZD5462 Status COMPLETED Phase PHASE1